Trexquant Investment’s GSK GSK Stock Holding History

Trexquant Investment’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-121,746	Closed	-$4.51M	–	1556
2023 Q4	$4.51M	Buy	121,746 +115,022	+1,711%	+$4.13M	0.1%	287
2023 Q3	$244K	Buy	+6,724	New	+$239K	0.01%	1293
2023 Q2	–	Sell	-50,113	Closed	-$1.78M	–	1566
2023 Q1	$1.78M	Sell	50,113 -40,567	-45%	-$1.42M	0.05%	500
2022 Q4	$3.19M	Buy	+90,680	New	+$3.02M	0.09%	296
2022 Q3	–	Sell	-63,907	Closed	-$3.48M	–	1550
2022 Q2	$3.48M	Buy	63,907 +43,260	+210%	+$2.39M	0.16%	150
2022 Q1	$1.12M	Buy	20,647 +14,729	+249%	+$800K	0.05%	443
2021 Q4	$326K	Buy	+5,918	New	+$308K	0.02%	870
2021 Q1	–	Sell	-24,348	Closed	-$1.12M	–	1248
2020 Q4	$1.12M	Buy	+24,348	New	+$1.12M	0.12%	231
2019 Q2	–	Sell	-102,469	Closed	-$5.35M	–	930
2019 Q1	$5.35M	Buy	+102,469	New	+$5.12M	0.38%	51
2018 Q1	–	Sell	-11,903	Closed	-$528K	–	1198
2017 Q4	$528K	Buy	+11,903	New	+$550K	0.06%	489
2017 Q1	–	Sell	-4,960	Closed	-$239K	–	1170
2016 Q4	$239K	Buy	+4,960	New	+$245K	0.04%	745
2016 Q1	–	Sell	-56,214	Closed	-$2.83M	–	1009
2015 Q4	$2.83M	Buy	+56,214	New	+$2.87M	0.25%	83

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's GSK Position: Q1 2024 in Review

Trexquant Investment sold out of GSK (GSK) in Q1 2024, closing a stake of 121,746 shares — an estimated $4.51M sold.

Trexquant Investment first reported a position in GSK in Q4 2015 and held it in 12 quarters. The position peaked at $5.35M in Q1 2019. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Trexquant Investment reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
Trexquant Investment sold 121,746 GSK shares in Q1 2024, an estimated $4.51M.
Trexquant Investment first reported a position in GSK in Q4 2015 and held it in 12 quarters.
Trexquant Investment's GSK position peaked at $5.35M in Q1 2019.
910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Trexquant Investment's 13F filing for Q1 2024, filed 14 May 2024.